Clarus Therapeutics Holdings, Inc. (CRXT) Social Stream



Clarus Therapeutics Holdings, Inc. (CRXT): $0.05

-0.02 (-31.16%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CLARUS THERAPEUTICS HOLDINGS INC (CRXT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRXT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 5 $20 $10 $13.4 $0.325 4023.08%
2021-11-24 5 $20 $10 $13.8 $0.325 4146.15%
2022-01-20 5 $20 $7 $13.2 $0.325 3961.54%
2022-03-31 5 $14 $3 $9.8 $0.325 2915.38%
2022-04-08 5 $14 $3 $7.2 $0.325 2115.38%
2022-05-17 4 $8 $3 $5.5 $0.325 1592.31%
2022-06-03 4 $8 $1.5 $3.875 $0.325 1092.31%

The Trend in the Analyst Price Target


CRXT's average price target has moved down $9.32 over the prior 134 days.

Over the past 33 weeks, CRXT's average upside potential has been 517.17%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-24 5 20 10 13.8 5.050 173.27%
2022-01-20 5 20 7 13.2 1.460 804.11%
2022-03-31 5 14 3 9.8 1.490 557.72%
2022-04-08 5 14 3 7.2 1.220 490.16%
2022-05-17 4 8 3 4.5 0.452 895.58%

CRXT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 1 0 0 0 4

The Trend in the Broker Recommendations


CRXT's average broker recommendation rating worsened by 0.05 over the prior 92 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRXT as an investment opportunity.

  • In the context of all US stocks, CLARUS THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 893.82% of them.
  • CRXT has a higher average analyst price target than 77.46% of all US stocks.
  • In terms of how CLARUS THERAPEUTICS HOLDINGS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -682.15% of that group.
  • In terms of how CLARUS THERAPEUTICS HOLDINGS INC fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 757.38% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CLARUS THERAPEUTICS HOLDINGS INC are CGTX, CDTX, and AZYO.

Is CRXT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5904 seconds.